Green and Hill Industries, Inc Stock Other OTC
Equities
GHIL
US39260U1060
Pharmaceuticals
Financials (USD)
Sales 2013 | - | Sales 2014 | 0 | Capitalization | 103 |
---|---|---|---|---|---|
Net income 2013 | - | Net income 2014 | - | EV / Sales 2013 * | - |
Net cash position 2013 * | - | Net cash position 2014 * | - | EV / Sales 2014 * | - |
P/E ratio 2013 * |
-
| P/E ratio 2014 * |
-
| Employees | - |
Yield 2013 * |
-
| Yield 2014 * |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ross Rebagliati
CEO | Chief Executive Officer | - | 14-03-16 |
Patrick Smyth
PSD | President | - | 14-03-16 |
Lorne Green
SEC | Corporate Secretary | - | 13-01-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Smyth
PSD | President | - | 14-03-16 |
Lorne Green
SEC | Corporate Secretary | - | 13-01-11 |
Ross Rebagliati
CEO | Chief Executive Officer | - | 14-03-16 |
1st Jan change | Capi. | |
---|---|---|
-15.69% | 4.49B | |
-9.75% | 3.06B | |
+2.14% | 3.04B | |
-6.82% | 2.61B | |
+47.87% | 1.81B | |
+0.84% | 1.66B | |
-7.89% | 1.63B | |
-12.03% | 1.55B | |
+36.40% | 1.41B |